Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 15.50 |
| Open | 15.28 |
| Bid | 15.50 x 3200 |
| Ask | 15.53 x 1500 |
| Day's Range | 13.50 - 15.70 |
| 52 Week Range | 3.53 - 17.40 |
| Volume | |
| Avg. Volume | 12,541,700 |
| Market Cap | 2.285B |
| Beta (5Y Monthly) | 1.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.60 |
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comArbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
ZacksVaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
© 2024 Yahoo. All rights reserved.